Entity

Time filter

Source Type

Vitry-sur-Seine, France

Aventis Pharma Limited, headquartered in Mumbai, is a part of Sanofi-Aventis group. Sanofi-Aventis and its 100% subsidiary Hoechst AG, are the major shareholders of Aventis Pharma Limited. Its manufacturing portfolio contains medicines for several therapeutic areas including cardiovascular, thrombotic, metabolic disorders, oncology, disorders of the central nervous system, internal medicine. Its primarily business is medicines in the dosage forms of liquid injectables, tablets, capsules, ointments, drops and syrup. In July 2003, company launched Lantus, the world's first and only once a day insulin. Wikipedia.


Patent
Aventis Pharma | Date: 2014-08-07

The invention concerns nucleic acids coding for mutated or truncated forms of the human parkin gene, or forms comprising multiplication of exons, and the corresponding proteins and antibodies. The invention also concerns methods and kits for identifying mutations of the parkin gene, and for studying compounds for therapeutic purposes.


The invention relates to anhydrides, solvates and ethanol hetero-solvates and hydrates of dimethoxy docetaxel or (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate of 4-acetoxy-2-benzoyloxy-5,20-epoxy-1-hydroxy-7, 10-dimethoxy-9-oxo-tax-11-ene-13-yle, and to the preparation thereof.


Patent
Aventis Pharma | Date: 2013-06-12

A composition comprising at least one physiologically tolerated film-forming agent, at least one physiologically tolerated solvent, at least one plasticizer and a compound of the formula I or a stereoisomeric form or a physiologically tolerated salt of any of the foregoing. The composition is suitable for treatment of androgenic alopecia or hirsutism, that is, for avoiding undesirable hair growth, and for treatment of seborrhea and acne, and can furthermore be employed in cosmetics.


The invention relates to anhydrides, solvates and ethanol hetero-solvates and hydrates of dimethoxy docetaxel or (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate of 4-acetoxy-2-benzoyloxy-5,20-epoxy-1-hydroxy-7, 10-dimethoxy-9-oxo-tax-11-ene-13-yle, and to the preparation thereof.


Patent
Aventis Pharma | Date: 2014-08-07

The present invention relates to the compound of formula (I): which may be in the form of an anhydrous base, a hydrate or a solvate,

Discover hidden collaborations